|
市場調査レポート
商品コード
1747275
創薬プラットフォーム市場：薬剤タイプ別、技術別、治療領域別、用途別、エンドユーザー別、地域別Drug Discovery Platforms Market, By Drug Type, By Technology, By Therapeutic Area, By Application, By End User, By Geography |
||||||
カスタマイズ可能
|
|||||||
価格
| 創薬プラットフォーム市場：薬剤タイプ別、技術別、治療領域別、用途別、エンドユーザー別、地域別 |
|
出版日: 2025年05月08日
発行: Coherent Market Insights
ページ情報: 英文 140 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
概要
世界の創薬プラットフォーム市場は、2025年には2億1,130万米ドルと推定され、2032年には5億1,290万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は13.5%で成長すると予測されています。
| レポート範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年の市場規模 | 2億1,130万米ドル |
| 実績データ | 2020年から2024年まで | 予測期間 | 2025年から2032年 |
| 予測期間：2025年～2032年 CAGR： | 13.50% | 2032年の価値予測 | 5億1,290万米ドル |
世界の創薬プラットフォーム市場は、新規治療薬に対する需要の高まりと、より効率的な創薬プロセスの必要性によって、近年大きな成長を遂げています。創薬プラットフォームは、ハイスループット・スクリーニング、ゲノミクス、プロテオミクス、計算ツールなどの先進技術を活用し、新薬候補の同定と開発に重要な役割を果たしています。これらのプラットフォームにより、研究者は創薬プロセスを合理化し、コストを削減し、初期スクリーニングから臨床試験までの期間を短縮することができます。市場には、生化学的アッセイ、細胞ベースのアッセイ、インシリコモデリング、フラグメントベースの創薬など、さまざまなタイプのプラットフォームが含まれます。創薬プラットフォームの採用は、慢性疾患の蔓延、個別化医療の台頭、製薬企業と学術機関の共同研究の増加によってさらに加速しています。
市場力学：
世界の創薬プラットフォーム市場は、慢性疾患の有病率の増加、個別化医療の需要の高まり、より効率的な創薬プロセスの必要性など、いくつかの要因によって牽引されています。がん、心血管疾患、神経疾患の有病率の上昇は、新規治療薬に対する大きな需要を生み出し、創薬プラットフォーム市場の成長を促進しています。さらに、個別化医療へのシフトにより、標的治療の開発が必要となっており、特定の分子標的を同定し、薬剤候補を最適化するための創薬プラットフォームに大きく依存しています。しかし、創薬と市場開拓に関連する高いコストや、医薬品承認に必要な厳しい規制要件が市場の成長を抑制しています。さらに、熟練した専門家の不足や、さまざまな技術を統合することの複雑さが、市場成長の課題となっています。こうした市場抑制要因にもかかわらず、市場には、創薬における人工知能や機械学習の採用の増加、希少疾患への注目の高まり、革新的な創薬ソリューションを開発するための製薬企業とテクノロジープロバイダーとの協業の可能性など、大きなビジネスチャンスが存在します。
本調査の主な特徴
- 本レポートでは、世界の創薬プラットフォーム市場を詳細に分析し、2024年を基準年とした予測期間（2025年～2032年）の市場規模（USD Mn）および複合年間成長率（CAGR%）を掲載しています。
- また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
- また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
- 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の創薬プラットフォーム市場における主要企業プロファイルを掲載しています。
- 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関して、情報に基づいた意思決定を行うことができます。
- 世界の創薬プラットフォーム市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
- 利害関係者は、世界の創薬プラットフォーム市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場の展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
第3章 市場力学、規制、動向分析
- 市場力学
- 促進要因
- 抑制要因
- 機会
- 影響分析
- 主な発展
- 規制シナリオ
- 製品の発売/承認
- PEST分析
- PORTERの分析
- 合併と買収のシナリオ
- 業界動向
第4章 世界の創薬プラットフォーム市場、薬剤タイプ別、2020年～2032年
- 小分子
- 巨大分子
第5章 世界の創薬プラットフォーム市場、技術別、2020年～2032年
- ゲノミクス
- プロテオミクス
- 細胞ベースアッセイ
- ハイスループットスクリーニング（HTS）
- バイオインフォマティクス
- 次世代シーケンシング（NGS）
- 質量分析
- イメージングテクノロジー
- マイクロ流体工学
- 人工知能（AI）と機械学習（ML）
第6章 世界の創薬プラットフォーム市場、治療領域別、2020年～2032年
- 腫瘍学
- 神経学
- 感染症および免疫系疾患
- 消化器系疾患
- 心血管疾患
- 糖尿病
- 呼吸器疾患
第7章 世界の創薬プラットフォーム市場、用途別、2020年～2032年
- ターゲット識別
- ターゲット検証
- リード発見
- リード最適化
- 前臨床試験
- その他（臨床試験等）
第8章 世界の創薬プラットフォーム市場、エンドユーザー別、2020年～2032年
- バイオ医薬品企業
- 学術研究機関
- CRO/CDMO
- その他
第9章 世界の創薬プラットフォーム市場、地域別、2020年～2032年、価値
- 北米
- 米国
- カナダ
- ラテンアメリカ
- ブラジル
- アルゼンチン
- メキシコ
- その他ラテンアメリカ
- 欧州
- ドイツ
- 英国
- スペイン
- フランス
- イタリア
- ロシア
- その他欧州
- アジア太平洋
- 中国
- インド
- 日本
- オーストラリア
- 韓国
- ASEAN
- その他アジア太平洋地域
- 中東
- GCC諸国
- イスラエル
- その他中東
- アフリカ
- 南アフリカ
- 北アフリカ
- 中央アフリカ
第10章 競合情勢
- Thermo Fisher Scientific
- Agilent Technologies
- Danaher Corporation
- PerkinElmer
- Merck KGaA
- Roche Holding AG
- QIAGEN
- Bruker Corporation
- Bio-Rad Laboratories
- Illumina
- Charles River Laboratories
- Evotec
- WuXi AppTec
- Schrodinger
- Abcam
第11章 アナリストの推奨事項
- 機会
- アナリストの見解
- Coherent Opportunity Map
第12章 参考文献と調査手法
- 参考文献
- 調査手法
- 出版社について
目次
Product Code: CMI7896
Global Drug Discovery Platforms Market is estimated to be valued at USD 211.3 Mn in 2025 and is expected to reach USD 512.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 13.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 211.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 13.50% | 2032 Value Projection: | USD 512.9 Mn |
The global drug discovery platforms market has witnessed significant growth in recent years, driven by the increasing demand for novel therapeutics and the need for more efficient drug discovery processes. Drug discovery platforms play a crucial role in the identification and development of new drug candidates, utilizing advanced technologies such as high-throughput screening, genomics, proteomics, and computational tools. These platforms enable researchers to streamline the drug discovery process, reduce costs, and accelerate the timeline from initial screening to clinical trials. The market encompasses various types of platforms, including biochemical assays, cell-based assays, in silico modeling, and fragment-based drug discovery. The adoption of drug discovery platforms has been further fueled by the growing prevalence of chronic diseases, the emergence of personalized medicine, and the increasing collaboration between pharmaceutical companies and academic institutions.
Market Dynamics:
The global drug discovery platforms market is driven by several factors, including the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the need for more efficient drug discovery processes. The rising prevalence of cancer, cardiovascular diseases, and neurological disorders has created a significant demand for novel therapeutics, propelling the growth of the drug discovery platforms market. Additionally, the shift towards personalized medicine has necessitated the development of targeted therapies, which rely heavily on drug discovery platforms for identifying specific molecular targets and optimizing drug candidates. However, the market growth is restrained by the high cost associated with drug discovery and development, as well as the stringent regulatory requirements for drug approval. Furthermore, the lack of skilled professionals and the complexity of integrating various technologies pose challenges to market growth. Despite these restraints, the market presents significant opportunities, such as the increasing adoption of artificial intelligence and machine learning in drug discovery, the growing focus on rare diseases, and the potential for collaborations between pharmaceutical companies and technology providers to develop innovative drug discovery solutions.
Key Features of the Study:
- This report provides in-depth analysis of the global drug discovery platforms market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global drug discovery platforms market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Agilent Technologies, Danaher Corporation, PerkinElmer, Merck KGaA, Roche Holding AG, QIAGEN, Bruker Corporation, Bio-Rad Laboratories, Illumina, Charles River Laboratories, Evotec, WuXi AppTec, Schrodinger, and Abcam
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global drug discovery platforms market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug discovery platforms market
Market Segmentation
- Drug Type Insights (Revenue, USD Mn, 2020 - 2032)
- Small Molecule
- Large Molecule
- Technology Insights (Revenue, USD Mn, 2020 - 2032)
- Genomics
- Proteomics
- Cell-Based Assays
- High-Throughput Screening (HTS)
- Bioinformatics
- Next-Generation Sequencing (NGS)
- Mass Spectrometry
- Imaging Technologies
- Microfluidics
- Artificial Intelligence (AI) & Machine Learning (ML)
- Therapeutic Area Insights (Revenue, USD Mn, 2020 - 2032)
- Oncology
- Neurology
- Infectious And Immune System Diseases
- Digestive System Diseases
- Cardiovascular Diseases
- Diabetes
- Respiratory Disease
- Application Insights (Revenue, USD Mn, 2020 - 2032)
- Target Identification
- Target Validation
- Lead Discovery
- Lead Optimization
- Preclinical Testing
- Others (Clinical Trials, etc.)
- End User Insights (Revenue, USD Mn, 2020 - 2032)
- Biopharmaceutical Companies
- Academic and Research Institutes
- CROs/CDMOs
- Others
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- Agilent Technologies
- Danaher Corporation
- PerkinElmer
- Merck KGaA
- Roche Holding AG
- QIAGEN
- Bruker Corporation
- Bio-Rad Laboratories
- Illumina
- Charles River Laboratories
- Evotec
- WuXi AppTec
- Schrodinger
- Abcam
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Drug Discovery Platforms Market, By Drug Type
- Global Drug Discovery Platforms Market, By Technology
- Global Drug Discovery Platforms Market, By Therapeutic Area
- Global Drug Discovery Platforms Market, By Application
- Global Drug Discovery Platforms Market, By End User
- Global Drug Discovery Platforms Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Drug Discovery Platforms Market, By Drug Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Small Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Large Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Drug Discovery Platforms Market, By Technology, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Proteomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Cell-Based Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- High-Throughput Screening (HTS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Bioinformatics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Mass Spectrometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Imaging Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Microfluidics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Artificial Intelligence (AI) & Machine Learning (ML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Drug Discovery Platforms Market, By Therapeutic Area, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Infectious And Immune System Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Digestive System Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Drug Discovery Platforms Market, By Application, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Target Identification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Target Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Lead Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Lead Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Preclinical Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others (Clinical Trials, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Drug Discovery Platforms Market, By End User, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- CROs/CDMOs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Drug Discovery Platforms Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bruker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Schrodinger
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abcam
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
